Rapid-acting Treatments for Pediatric Depression and Suicidality: Where are We Now?
Brown University via Independent
-
111
-
- Write review
Overview
Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Jennifer B. Dwyer, MD, PhD
Co-Director Yale Pediatric Depression Program
Assistant Professor, Child Study Center and Dept of Radiology and Biomedical Imaging
Yale University
Syllabus
- Describe the proposed mechanism of action of novel rapid-acting anti-depressant and anti-suicidal pharmacotherapeutics
- Describe the state of the pediatric evidence base for rapid-acting treatments and to compare it with the adult evidence base
- Appreciate the unique developmental considerations that apply to testing and implementing novel therapeutics in the pediatric population